Mucosal treatment
AssigneeNtnu Technology Transfer AS
InventorsCatherine Taylor, Kurt Ingar Draget, Olav Asmund Smidsrod
Life of this patent
Estimating the term…
Abstract
The invention provides a method of treatment of a female human or non-human subject to enhance cervical mucus penetrability by spermatozoa, which method comprises vaginally applying to said subject an effective amount of a spermicide-free, physiologically tolerable oligouronate.
Claims29
A method of treatment of a female human or non-human subject to enhance cervical mucus penetrability by spermatozoa, which method comprises vaginally applying to said subject an effective amount of a spermicide-free, physiologically tolerable oligouronate.
A method of manufacturing a medicament comprising an oligouronate for vaginal application to enhance cervical mucus permeability to spermatozoa.
(canceled)
A sterile, spermicide-free vaginal treatment composition comprising a physiologically tolerable carrier or excipient together with an oligouronate and a pH regulator, optionally further comprising an agent selected from the group consisting of antioxidants, muscle relaxants and lubricants.
A method of treatment of a human or non-human subject to combat mucosal hyperviscosity in the digestive tract, which method comprises application to a mucosal surface of said tract in said subject of an effective amount of a physiologically tolerable oligouronate.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A pharmaceutical composition comprising a physiologically tolerable oligouronate together with a physiologically tolerable carrier or excipient.
A foodstuff or food additive comprising a nutrient material and a physiologically tolerable oligouronate.
A method of drug delivery comprising administering to a patient a composition containing oligoguluronic or oligogalacturonic acid.
Dependencies are inferred from the claim text.